ESAOTE launches MyLab™Gamma at European Society of Cardiology 2014

Esaote, one of the world’s leading manufacturers of medical diagnostic systems, is launching MyLab™Gamma, a best in class, highly-portable “green” ultrasound system at ESC Congress (European Society of Cardiology, Barcelona, 30th August - 3rd September). Based on Esaote’s productivity-oriented operating platform, the super-light, feature packed portable system sets ultrasound free to be used in any environment - at a moment’s notice.

Highly portable and battery-operated, the MyLab™Gamma offers fast boot times and a rapid resume from standby mode that means the system is ready to use within seconds. Integration of wireless connectivity, a class leading feature for a system of its size and price, facilitates easy, one-click networking with other systems and local networks as required.

“MyLab™Gamma finally sets ultrasound free,” says Joop Geijsen, Ultrasound Project Manager at Esaote. “We now bring superb quality images and fast, accurate diagnosis right to the point-of-care in any situation – wherever and whenever.”

FAST, SIMPLE TO USE, COMFORTABLE

Esaote, a recognised leader in ergonomics and design lead simplicity, has engineered the MyLab™Gamma to meet the rigorous demands of the sonographer’s working environment, particularly those using ultrasound systems for many hours a day. Esaote’s simple-to-use, Touch screen-based interface guides the operator through set-up and image capture, enabling faster workflow. A high resolution widescreen monitor can be rotated through +90/-90 degrees to increase comfort, and allows an examination to be shared with the patient or colleague. An almost silent cooling system improves the quality of the working environment and reduces  operator disturbance.

Two transducer connectors allow two probes to be connected to the system: switching the probe selection during an examination is simple, further increasing efficiency and workflow. An optional multi-connector is available, allowing up to four transducers to be connected and selected via the intuitive software interface. MyLab™Gamma also comes with remote service capabilities. The system can be recovered in the shortest time possible by simply connecting it to the network: Esaote’s Service Team can easily troubleshoot any issue, perform proactive maintenance and monitor performance.

Optimal solution for a range of applications

Incorporating high resolution imaging, advanced technologies, and supporting a range of probes, MyLab™Gamma is an optimal ultrasound solution for cardiovascular and a range of other applications

  • For cardiovascular applications, MyLab™Gamma is equipped with comprehensive cardiac and vascular ultrasound packages, and provides excellent image quality in a very compact size. Advanced tools (QIMT, XStrain™(*), TEE Probe, Post Processing, Wireless connectivity - customizable measurements and flexible configuration - coupled with a tailored reporting package - make MyLabTMGamma the complete solution for cardiovascular scanning in the clinic and on the move.
  • MyLab™Gamma’s is also well-suited to other applications, including general imaging, women’s health, anaesthesiology, emergency and critical care. The system represents an ideal solution from Point-of-Care to shared Ultrasound services.

MyLabTMGamma comes with a  2 year additional device warranty package to the current standard warranty period  (excludes probes, carts and accessories).

(*) Available through MyLab™Desk3 software suite

MyLabTMDesk3 software suite is not intended or provided for an official diagnostic interpretation.

ABOUT ESAOTE

With €276.1 million in consolidated sales in 2013 (of which 65% were generated from international markets), Esaote Group is a leading player in the biomedical equipment sector, with a particular focus on ultrasound, dedicated magnetic resonance, and software for managing the diagnostic process. Esaote has over 1,335 employees, 19% of which are employed in R&D activities. Esaote has industrial and research units in Italy (Genoa, Florence, Naples), the Netherlands (Maastricht) and China (Shenzhen). Esaote is internationally recognised as one of the “Top Ten” diagnostic imaging companies in the world and enjoys the co-operation of worldwide scientific and clinical research centres and universities. Esaote has filed more than 120 international patents.

Information about the Esaote Group and its products is available at www.esaote.com

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
More than half of all US adults are eligible for semaglutide therapy